Antibiotice will increase the export value to the US market
The beginning of 2013 augurs well for Antibiotice. A few days ago, the company’s representatives signed two business contracts with two major distributors on the USA market, assuring this way the delivery of medicines for injection in 2013.
The two contracts are concluded for exporting 6 anti-infective medicines for injection (four of them are already on the US market together with two new ones added) from Antibiotice portfolio, FDA authorized for the American market.
This business partnership is the result of the two audits conducted in December 2012 by the above-mentioned distributors, on the injectable penicillins manufacturing line and of the renewal of the authorization granted by the FDA, the American Regulatory Agency in January 2013.
In May and June 2013 new negotiations will be held with the distributors on the American market for concluding new trade contracts.